Related Experiment Video
Updated: Nov 30, 2025

06:43
Intravenous and Intra-amniotic In Utero Transplantation in the Murine Model
Published on: October 9, 2018
10.0K
Delivery technologies for in utero gene therapy
Rohan Palanki1, William H Peranteau2, Michael J Mitchell3
1Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Department of Bioengineering, University of Pennsylvania, Philadelphia, PA 19104, USA.
Advanced Drug Delivery Reviews
|November 12, 2020
Summary
In utero gene therapy offers a promising approach to correct genetic disorders before birth. Key challenges involve ensuring biocompatibility and efficient delivery of therapeutic genes within the womb.
Area of Science:
- Reproductive Biology
- Genetics
- Biotechnology
Background:
- Prenatal diagnostics and fetal interventions enable early treatment of congenital diseases.
- In utero gene therapy offers potential for widespread genetic disorder correction during gestation.
- Current limitations include biocompatibility and efficient intracellular transgene delivery for in utero gene therapy.
Purpose of the Study:
- To review delivery considerations for in utero gene therapy components.
- To highlight advancements in viral and non-viral delivery platforms for fetal gene therapy.
- To discuss gene editing delivery technologies and future directions for clinical translation.
Main Methods:
- Review of current literature on prenatal diagnostics and fetal interventions.
- Analysis of viral and non-viral delivery systems for in utero gene therapy.
- Exploration of gene editing technologies and delivery strategies for prenatal applications.
Main Results:
- Progress in prenatal imaging and genetic screening facilitates early intervention.
- Viral and non-viral vectors show promise for overcoming delivery challenges in fetal gene therapy.
- Specialized delivery technologies are emerging for in utero gene editing.
Conclusions:
- In utero gene therapy holds significant potential for treating genetic disorders prenatally.
- Overcoming delivery and biocompatibility challenges is crucial for clinical translation.
- Continued innovation in delivery modalities is essential for advancing fetal gene therapy.
Related Concept Videos
Gene Therapy
27.0K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.0K
In-vitro Mutagenesis
15.7K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
15.7K

